Roche Holding | ROG - Beban Penjualan Dan Administrasi





Beban Penjualan Dan Administrasi Perubahan Tanggal
AbbVie USD 3.63B 54M 2026-06
Alcon AG USD 964M 82M 2026-06
Amgen USD 1.72B 134M 2026-06
AstraZeneca USD 5.8B 735M 2026-06
Bayer EUR 3.96B 267M 2026-06
Biogen USD 752M 42.3M 2026-09
Bristol-Myers Squibb USD 1.7B 127M 2026-09
Eli Lilly USD 3.12B 305M 2026-09
Fresenius EUR 760M 17M 2026-06
Fresenius Medical Care EUR 736.01M 12.99M 2026-06
Genmab DKK 205M 39M 2026-06
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
GRIFOLS EUR 289M 8M 2026-06
Hikma Pharmaceutical USD 288M 149M 2025-12
Lakefront Biotherapeutics EUR 22.5M 13M 2026-06
Merck EUR 1.57B 49M 2026-06
Merck USD 2.86B 25M 2026-09
Novartis USD 3.24B 101M 2026-06
Orion EUR 98.9M 0 2026-09
Pfizer USD 3.41B 496M 2026-06
Philips EUR 1.21B 23M 2026-06
Recordati EUR 201.58M 8.82M 2026-06
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.63B 307M 2026-06
UCB EUR 1.47B 193M 2025-12